Czechia· CZ-0250271
PHESGO
A pertuzumab und trastuzumab product containing pertuzumab + trastuzumab, registered in Czechia by Roche Registration GmbH, Grenzach-Wyhlen. The same ATC class is registered in 10 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Pertuzumab und trastuzumab is registered in 10 of 19 countries.
Countries holding a registration under ATC L01FY01 (pertuzumab und trastuzumab), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 7 of them publish a price we can compare per daily dose
Pertuzumab und trastuzumab · ATC L01FY01
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- PERTUZUMAB + TRASTUZUMAB
- Manufacturer
- Roche Registration GmbH, Grenzach-Wyhlen
- Country
- Czechia (CZ)
- ATC code
- L01FY01
- ATC class
- Pertuzumab und Trastuzumab
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl02502711X10MLCZK 103507.49
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pertuzumab und trastuzumab in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandPhesgoRoche Registration GmbH
- SpainPHESGO 1200 MG/600 MG SOLUCION INYECTABLERoche Registration Gmbh
- FinlandPhesgoAbacus Medicine A/S
- CanadaPERJETA-HERCEPTINHOFFMANN-LA ROCHE LIMITED
- United KingdomPhesgo 1200mg/600mg/15ml solution for injection vialsRoche Products Ltd
- IrelandPhesgo 1200 mg/600 mg solution for injectionRoche Registration GmbH
- IcelandPhesgoRoche Registration GmbH*
- NetherlandsPhesgo 1200/600 mg, oplossing voor injectie in injectieflaconRoche Registration GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Phesgo
- Liechtenstein · Phesgo
- Norway · Phesgo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/48d0036e-d676-4948-8194-65bcc4260d05 GET /v1/drugs/48d0036e-d676-4948-8194-65bcc4260d05?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SOL",
"source": "sukl",
"strength": "600MG/600MG",
"pack_size": "1X10ML",
"substance": "PERTUZUMAB + TRASTUZUMAB",
"cz_kod_sukl": "0250271",
"product_type": "BT",
"substance_codes": "16997,15536",
"registration_state": "R",
"registration_number": "EU/1/20/1497/002"
}See everything about pertuzumab und trastuzumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.